New Study: Natural Immunity Provides Robust Protection Against Delta Variant
Previous SARS-CoV-2 infection is highly protective against reinfection with the COVID-19 (Coronavirus Disease 2019) Delta variant, according to a new study published on Dec. 3, 2021 in the Clinical Infectious Diseases journal by researchers at...
Pharmaceutical Companies Making Billions From COVID-19 Booster Shots
The COVID-19 pandemic has already raked in billions of dollars of revenue for vaccine manufacturers. As booster shots get approved worldwide, these companies stand to make even more. In the United States, health officials have...
FDA Approves COVID-19 Boosters for Seniors, People at High Risk; Pfizer Seeks Approval to Vaccinate Children
On Sept. 22, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer COVID-19 vaccine to allow it to be used as a booster shot among certain populations. The...
